Literature DB >> 34967406

Balancing Act: Precision Medicine and National Security.

Diane DiEuliis1, James Giordano2,3.   

Abstract

Developments in genetics, pharmacology, biomarker identification, imaging, and interventional biotechnology are enabling medicine to become increasingly more precise in "personalized" approaches to assessing and treating individual patients. Here we describe current scientific and technological developments in precision medicine and elucidate the dual-use risks of employing these tools and capabilities to exert disruptive influence upon human health, economics, social structure, military capabilities, and global dimensions of power. We advocate continued enterprise toward more completely addressing nuances in the ethical systems and approaches that can-and should-be implemented (and communicated) to more effectively inform policy to guide and govern the biosecurity and use of current and emerging bioscience and technology on the rapidly shifting global stage. Published by Oxford University Press on behalf of the Association of Military Surgeons of the United States 2021. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Mesh:

Year:  2021        PMID: 34967406      PMCID: PMC8717320          DOI: 10.1093/milmed/usab017

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  5 in total

1.  The Emerging Neurobioeconomy: Implications for National Security.

Authors:  Joseph DeFranco; Maureen Rhemann; James Giordano
Journal:  Health Secur       Date:  2020 Jul/Aug

2.  Rethinking the Biological and Toxin Weapons Convention?

Authors:  Daniel Gerstein; James Giordano
Journal:  Health Secur       Date:  2017-11-14

3.  Identification of individuals by trait prediction using whole-genome sequencing data.

Authors:  Christoph Lippert; Riccardo Sabatini; M Cyrus Maher; Eun Yong Kang; Seunghak Lee; Okan Arikan; Alena Harley; Axel Bernal; Peter Garst; Victor Lavrenko; Ken Yocum; Theodore Wong; Mingfu Zhu; Wen-Yun Yang; Chris Chang; Tim Lu; Charlie W H Lee; Barry Hicks; Smriti Ramakrishnan; Haibao Tang; Chao Xie; Jason Piper; Suzanne Brewerton; Yaron Turpaz; Amalio Telenti; Rhonda K Roby; Franz J Och; J Craig Venter
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-05       Impact factor: 11.205

4.  Gene editing using CRISPR/Cas9: implications for dual-use and biosecurity.

Authors:  Diane DiEuliis; James Giordano
Journal:  Protein Cell       Date:  2018-03       Impact factor: 14.870

5.  Editorial: Mapping the Cyberbiosecurity Enterprise.

Authors:  Randall Murch; Diane DiEuliis
Journal:  Front Bioeng Biotechnol       Date:  2019-10-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.